Both symptomatic and asymptomatic neurocognitive impairment in HIV are associated with a higher risk for low/very low viremia and viral failure. “The HIV landscape has changed quickly during the last 10 years,” Mattia Trunfio, MD, PhD, notes....
Neurology
RELEVANT ARTICLES IN Neurology
Adjunctive treatment with argatroban or eptifibatide does not improve post-stroke functional outcomes
Adjunctive treatment with argatroban or eptifibatide does not improve post-stroke functional outcomes
1. In this randomized controlled trial, among ischemic stroke patients treated with intravenous thrombolysis, it was found that adjunctive intravenous argatroban or eptifibatide did not reduce disability 90 days post-stroke compared with placebo. 2. Symptomatic...
California Bans 6 Artificial Dyes in Foods Served at Public Schools
California Bans 6 Artificial Dyes in Foods Served at Public Schools
TUESDAY, Oct. 1, 2024 (HealthDay News) -- A new law just passed in California makes it the first state to tell public schools they may no longer serve foods that contain six artificial dyes linked to health and behavior problems among children.Gov. Gavin Newsom...
Advertisement
E-Bike, Scooter Injury Rates Increased in Recent Years
E-Bike, Scooter Injury Rates Increased in Recent Years
TUESDAY, Oct. 1, 2024 (HealthDay News) -- The incidence of severe injuries from powered micromobility devices increased from 2019 to 2022, according to a study published online Sept. 12 in the American Journal of Public Health.Kathryn G. Burford, Ph.D., from...
Infusion with a monoclonal antibody decreases migraine frequency
Infusion with a monoclonal antibody decreases migraine frequency
1. In this randomized controlled trial, in patients diagnosed with migraine, it was found that administration of a monoclonal antibody against pituitary adenylate cyclase-activating polypeptide (PACAP), Lu AG09222, was associated with a reduction in migraines...
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
MONDAY, Sept. 30, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, in combination with the enzyme inhibitor miglustat, is...
Adjunctive treatment with argatroban or eptifibatide does not improve post-stroke functional outcomes
Adjunctive treatment with argatroban or eptifibatide does not improve post-stroke functional outcomes
1. In this randomized controlled trial, among ischemic stroke patients treated with intravenous thrombolysis, it was found that adjunctive intravenous argatroban or eptifibatide did not reduce disability 90 days post-stroke compared with placebo. 2. Symptomatic...
California Bans 6 Artificial Dyes in Foods Served at Public Schools
California Bans 6 Artificial Dyes in Foods Served at Public Schools
TUESDAY, Oct. 1, 2024 (HealthDay News) -- A new law just passed in California makes it the first state to tell public schools they may no longer serve foods that contain six artificial dyes linked to health and behavior problems among children.Gov. Gavin Newsom...
E-Bike, Scooter Injury Rates Increased in Recent Years
E-Bike, Scooter Injury Rates Increased in Recent Years
TUESDAY, Oct. 1, 2024 (HealthDay News) -- The incidence of severe injuries from powered micromobility devices increased from 2019 to 2022, according to a study published online Sept. 12 in the American Journal of Public Health.Kathryn G. Burford, Ph.D., from...
Infusion with a monoclonal antibody decreases migraine frequency
Infusion with a monoclonal antibody decreases migraine frequency
1. In this randomized controlled trial, in patients diagnosed with migraine, it was found that administration of a monoclonal antibody against pituitary adenylate cyclase-activating polypeptide (PACAP), Lu AG09222, was associated with a reduction in migraines...
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
MONDAY, Sept. 30, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, in combination with the enzyme inhibitor miglustat, is...
CONDITION SPOTLIGHTS
Condition Spotlight: Tardive Dyskinesia
A collection of feature articles, study abstracts, and additional resources all focused on tardive dyskinesia (TD).
ACTRIMS Forum 2024: Multiple Sclerosis
The latest news from ACTRIMS Forum 2024 focused on multiple sclerosis, including abstracts, features, and helpful conference information.
AAN 2023 Fall Conference: MS
The latest news from AAN 2023 Fall Conference on multiple sclerosis (MS), including featured articles and information about the conference.
2023 NACLC: NSCLC
The latest news from 2023 NACLC on non-small cell lung cancer (NSCLC), including abstracts, featured articles, and information about the conference.
Advertisement
Addressing Non-Adherence & Motivating Patients to Take an Active Role in Their Health
Addressing Non-Adherence & Motivating Patients to Take an Active Role in Their Health
Yvette C. Terrie, RPh, shares insights into addressing non-adherence and motivating patients to adhere to medication recommendations and health practices.
Helping Patients Understand That What They WANT Isn’t Always What They NEED
Helping Patients Understand That What They WANT Isn’t Always What They NEED
Patients have easy access to health information, so doctors must enhance efforts involving helping patients understand their conditions and treatment options.
Medical Fiction: Jiff & the Biotic Bear
Medical Fiction: Jiff & the Biotic Bear
In this medical fiction, a pampered heir's anti-antibiotic crusade ends after an encounter with a bear cub renders him a victim of his own misguided beliefs.
CME / CE
Spinal Cord Atrophy and Inflammation Help Predict MS Progression
This course discusses whether progression independent of relapse activity in multiple sclerosis is linked with the rate of spinal cord atrophy and the burden of brain paramagnetic rim lesions.
PODCAST
Advertisement
MORE STORIES IN Neurology
FILTER ARTICLES BY:
Advertisement
PODCAST
CARTOONS
ICD-10 Update Season
ICD-10 Update Season
Medical cartoon about ICD-10 codes raining down on the medical community during ICD-10-CM update season.
BUSINESS OF MEDICINE
2025 ICD-10-CM Codes Are Now in Effect: Key Updates You Need to Know
2025 ICD-10-CM Codes Are Now in Effect: Key Updates You Need to Know
2025 ICD-10-CM updates include new codes, code deletions and revisions, and a conversion table that identifies inactive codes and their replacements.
Why Physicians Should Consider Supporting a Patient’s Desire for a Second Opinion
Why Physicians Should Consider Supporting a Patient’s Desire for a Second Opinion
Although a patient's request for a second opinion can make a physician question the patient’s trust level, physicians should consider supporting that desire.
Is This New Practice Model the Cure for Physician Burnout & the Future of Primary Care?
Is This New Practice Model the Cure for Physician Burnout & the Future of Primary Care?
Working in a concierge healthcare system allows doctors to reclaim their primary role in patient care and reconnect with meaning in their practice of medicine.
ADVERTISEMENT
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.